Unfortunately, participants were not asked about gastrointestinal symptoms during the experiment and the caliber of the mesenteric arteries was not measured, so whether the 12 participants with increased I-FABP levels had mesenteric artery stenosis, atherosclerosis, or chronic intestinal ischemia is unknown [19]. Here, FABP2 is linked to atherosclerosis.